Edmentum Releases New Study Island Research That Shows

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
150
Edmentum Releases New Study Island Research That Shows Significant Effect on Improving Student Outcomes

Minneapolis, Minnesota, June 26, 2018 (GLOBE NEWSWIRE) -- Edmentum , a global education leader and a pioneer in online teaching and learning solutions, is pleased to release a new research study – Impacts of the Use of Study Island Practice and Benchmarks . Edmentum is founded in research with over 60 years of curriculum experience. Study This study is the latest in Edmentum’s commitment to rigorous research and efficacy surrounding its programs. Results of the study indicate that Study Island has a statistically significant effect on improving student outcomes based on moderate levels of evidence.

“A deep commitment to improving student outcomes through our solutions is of paramount importance at Edmentum,” said Karen Barton, PhD, Senior Vice President of Research and Design at Edmentum. “To ensure we are meeting the specific needs of educators and learners across the country, we are growing our research base and partnering with innovative schools and districts, such as the Pennsylvania district in this study, to support program effectiveness and success.”

This new study for Study Island reflects best practice in research that goes beyond product access and aggregate, school level analyses. This student-level study provides detailed analyses of  student usage of and performance in Study Island compared to those students’ performance on the state level assessment.  The study goes even further by matching students based on their previous state level assessment for more rigorous comparisons, reflecting Level 3 ESSA Evidence requirements. Through a series of descriptive and statistical analyses, this study found statistically significant and positive impacts on state test scores for students using Study Island.

“We are very excited to release this new research that demonstrates Study Island’s effectiveness,” said Dave Adams, Chief Academic Officer at Edmentum. “Edmentum is committed to making it easier for educators to individualize learning for every student by delivering quality, research-based programs designed to meet the evolving needs of educators. Our focus on high-quality research and efficacy underscores that passion.”  

Island’s customizable K-12 practice and assessment tool gives educators the flexibility and depth needed to support student learning and continuously engage, monitor, and assess progress. Study Island is backed by valid research studies, like the one completed in partnership with Allentown School District.

For more information on Study Island visit https://www.edmentum.com/products/study-island .

Edmentum

Edmentum, Inc. is committed to making it easier for educators to individualize learning for every student through simple technology, high-quality content, and actionable data. Founded in innovation, Edmentum’s powerful learning solutions blend technology with individual teaching approaches. Edmentum is committed to being educators’ most trusted partner in creating successful student outcomes everywhere learning occurs. Built on fifty years of experience in education, Edmentum solutions currently support educators and students in more than 40,000 schools nationwide. For more information, visit edmentum.com.

Media Contact

Luke Rowland lrowland@momentum-cg.com

Ashlee Tatum-Eckley Edmentum ashlee.tatum-eckley@edmentum.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

FDA Greenlights Kisqali®: A Major Step for Breast Cancer Care

Updated Category News Views 203

Kisqali® Receives FDA Approval for Early Breast Cancer Treatment Novartis has some exciting news for oncology: the US Food and Drug Administration (FDA) has officially approved Kisqali® (ribociclib) as a treatment for patients diagnosed with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) stage II and III early breast cancer...

Continue Reading
Ålandsbanken Abp Launches SEK 350M Additional Tier 1 Notes Series

Updated Category News Views 162

Ålandsbanken Abp Issues SEK 350,000,000 Additional Tier 1 Notes Ålandsbanken Abp, a prominent player in the banking industry, recently made waves in the financial market by issuing Additional Tier 1 floating rate notes amounting to SEK 350,000,000. The issuance marks a significant step in Ålandsbanken's strategic move to strengthen its capital position and enhance its...

Continue Reading
Harbour BioMed's 2025 Achievements and Future Prospects

Updated Category News Views 249

Harbour BioMed Achieves Significant Milestones in Interim Results Harbour BioMed (HKEX: 02142) is a prominent biopharmaceutical company focused on developing innovative antibody therapeutics, particularly in the fields of immunology and oncology. The company shared its impressive interim results for the first half of the year, showcasing remarkable growth and strategic...

Continue Reading
Innovative Investment Fuels Okika Devices' Future Growth Strategy

Updated Category News Views 187

Strategic Investment Boosts Okika Devices Advancement Colorado ONE Fund, which is part of the ONE Funds initiative, has made a major investment in Okika Devices, a company recognized for its innovation in Field Programmable Analog Array (FPAA) technology. This investment aligns with Colorado ONE Fund's mission to support technologies that advance the local innovation...

Continue Reading
Investors Take Note: Legal Options for Shareholders Explored

Updated Category News Views 61

Exploring Legal Options for Investors in Major Companies In recent developments, Halper Sadeh LLC, a reputable law firm focusing on investor rights, is carefully examining three significant companies for potential violations of federal securities laws. This investigation centers around the actions and decisions made by these firms, which may affect shareholders' rights...

Continue Reading